wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37449058-2643E5F8-CD77-4EB3-AF1D-926643FF1154
Q37449058-2643E5F8-CD77-4EB3-AF1D-926643FF1154
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37449058-2643E5F8-CD77-4EB3-AF1D-926643FF1154
Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab.
P2860
Q37449058-2643E5F8-CD77-4EB3-AF1D-926643FF1154
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37449058-2643E5F8-CD77-4EB3-AF1D-926643FF1154
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4a351c08fa0a7d8f0828351975ffca18a524eb2a
P2860
Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma.